logo
Plus   Neg
Share
Email

Sonoco Narrows 2018 Base Earnings Guidance - Quick Facts

Sonoco (SON) announced full-year 2018 base earnings per diluted share are expected to be in a range of $3.28 to $3.34, which narrows the previous estimate of $3.27 to $3.37 per diluted share. The company anticipates additional lost production and higher supply chain costs associated with Hurricane Florence could impact base fourth-quarter results by up to $0.03 per diluted share; of which, $0.02 per diluted share is included in the fourth-quarter base earnings guidance.

Full-year 2018 operating cash flow and free cash flow guidance has been raised to a range of $580 million to $600 million and $230 million to $250 million, respectively. Previous operating cash flow and free cash flow guidance was a range of $570 million to $590 million and $190 million to $210 million, respectively.

Sonoco expects fourth-quarter 2018 base earnings to be in the range of $0.75 to $0.81 per diluted share. Base earnings in the fourth quarter of 2017 were $0.72 per diluted share.

For the third-quarter, adjusted base earnings were $87.4 million, or $0.86 per diluted share, compared with $76.6 million, or $0.76 per diluted share, in 2017. Net sales were $1.36 billion, up 3.0 percent from $1.32 billion in 2017.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
RELATED NEWS
Follow RTT